Inhibition of PMA-induced Endothelial Cell Activation and Adhesion by Over-Expression of Domain Negative IκBα Protein

Jian-Feng Wei,Ke Sun,Shi-Guo Xu,Hai-Yang Xie,Shu-Sen Zheng
DOI: https://doi.org/10.3748/wjg.v11.i20.3080
2005-01-01
Abstract:AIM: NF-kappa B, regulate the expression of cytokine-inducible genes involving immune and inflammatory responses, will be potential therapy approach for allograft from rejection. In this study, we use pCMV-I kappa B alpha M vector to inhibit NF-kappa B activation and investigate the effect of pCMV-I kappa B alpha M in inhibition of T cells adhesion to endothelial cells.METHODS: The NF-kappa B activity was detected with pNF-kappa B reporter gene and electrophoretic mobility shift assay. Expression of cell surface molecules was detected by RT-PCR and flow cytometer. The cell-cell adhesion assay was performed to determine the effect of pCMV-I kappa B alpha M in inhibition of T cells adhesion to endothelial cells.RESULTS: We could find that NF-kappa B activity is inhibited by over-expression of non-degraded I kappa B alpha protein. Expression of adhesion molecules like ICAM-1, VCAM-1, and P-selectin as well as cell-cell adhesion were inhibited significantly by transfection of the pCMV-I kappa B alpha M vector.CONCLUSION: Our results indicate that the pCMV-I kappa B alpha M, which inhibit the activity of NF-kappa B through over-expression of non-degraded I kappa B alpha protein, can be used for gene therapy in diseases involving NF-kappa B activation abnormally like organ transplantation via inhibiting cell adhesion. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.
What problem does this paper attempt to address?